Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: Improving Anesthesia Protocols for Enhanced Mouse Acupuncture Research
Published on: December 8, 2023
Effect of acupuncture on ischemic stroke patients with hypertension: a randomized clinical trail
Wei Liu1, Boxuan Li1, Mengying Rong1,2
1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine, Tianjin, China.
Background:
Limited evidence suggests that acupuncture has a short-term antihypertensive effect. The efficacy and safety of acupuncture as an adjunctive treatment for ischemic stroke patients with hypertension were uncertain.
Objective:
To investigate the efficacy and safety of acupuncture as adjunctive therapy in reducing stroke recurrence and improving blood pressure for stroke patients with hypertension.
Design:
Multicenter randomized, controlled trial.
Methods:
18 centers from September 2015 to January 2020. 480 stroke participants with hypertension were randomized into adjunctive acupuncture group and basic treatment group to complete a 12-week treatment. The primary outcome was the one-year recurrence of stroke and the secondary outcome in 48-week follow-up included blood pressure, the Traditional Chinese Medicine syndrome score, the Short Form 36-item Health Survey, the National Institute of Health Stroke Scale, the Barthel Index scale, the ultrasound doppler, and serum tests.
Results:
There were no statistical differences between groups in primary outcome (p = 0.63 > 0.05). After 12-week treatment, adjunctive acupuncture group: (1) showed a higher participant proportion of dipper diastolic blood pressure pattern (p = 0.01 < 0.05); (2) had a better score on the Short Form 36-item Health Survey (p < 0.001); (3) decreased the vascular resistance of Right Internal Carotid Artery (p = 0.03 < 0 0.05).
Conclusion:
Adjunctive acupuncture therapy can improve stroke patients' circadian rhythm, carotid blood flow, and quality of life, but may not have a superior effect on reducing one-year stroke recurrence.
Clinical Trial Registration:
ClinicalTrials.gov, identifier NCT02967484.